[30P-pm348] Development of a compensated Förster resonance energy transfer (FRET) imaging for improved assessment of the pulmonary distribution of polymeric nanoparticles

○Kohei Togami^1,2, Yoshiki Hazama¹, Yuki Nakamura¹, Kiyomi Ishizawa¹, Sumio Chono^1,2 (1. Hokkaido University of Science, 2. Creation Research Institute of Life Science in KITA-no-DAICHI)

[30P-pm349S] Developmennt of transdermal absorbable nanoparticles containing prednisolone for the treatment of allergic contact dermatitis

○Ryo Fujisawa¹, Takeshi Oshizaka², Kenji Mori^1,2, Issei Takeuchi^1,2, Kenji Sugibayashi^1,2,3 (1. Grad. Sch. Pharm. Sci., Josai International Univ, 2. Josai International Univ., 3. Josai Univ.)

[30P-pm350S] Design and preparation of infection-sensing peptide depot for Staphylococcus aureus

○Momoka Hayashi¹, Kikka Kawamura¹, Taisei Chisaka¹, Akane Fujiu¹, Mizuho Kajikawa¹, Taisei Kanamoto¹, Daisuke Asai¹ (1. Lab. of Microbiol., Showa Pharmaceutical Univ.)

[30P-pm351S] Development of sustained release antimicrobial peptide drug responding to Psuedomonas aeruginosa-delived proteases

○Akane Fujiu^1,2, Taisei Chisaka^1,2, Momoka Hayashi¹, Mizuho Kajikawa¹, Taisei Kanamoto¹, Daisuke Asai¹ (1. Lab. of Microbiol., Showa Pharmaceutical Univ. , 2. contributed equally)

[30P-pm352] Formulation and in-vitro assessment of biocompatible pH-responsive nanogels of chitosan for sustained delivery of drug

○PAOCHU WU¹, I-Hui Chiu¹, Hamid Ullah¹ (1. Kaohsiung Medical University, School of Pharmacy)

[30P-pm353] Effects of DMAAm addition on the material properties of PNIPAAm hydrogel and dissolution properties of uranine

○Ami Somekawa¹, Chihiro Maeda¹, Shizue Kusumi¹, Asako Nishimura¹, Nobuhito Shibata¹ (1. Doshisha Women's College of Liberal Arts)

[30P-pm354S] The Utility of DMAAm Addition to Uranine-Containing PNIPAAm Hydrogel Formulation

○Chihiro Maeda¹, Ami Somekawa¹, Asako Nishimura¹, Nobuhito Shibata¹ (1. Doshisha Women's College of Liberal Arts)

[30P-pm355S] Effect of Pore-Supported Paclitaxel on Folate-Mesoporous Silica Nanoparticles in Folate Receptor High Expressing Cancer

○Tomoya Kubo¹, Yuta Goto¹, Rina Miyachi¹, Miyu Yasufuku¹, Chika Hanakawa¹, Tetuya Nakamura¹ (1. Fac.Pharm.Sci., Pharm.Sci., Fukuyama Univ.)

[30P-pm356S] Creating hepatocyte-specific drug delivery carrier by using hepatitis B virus-like particle (HBV-LP)

○Eri Takayama¹, Yuki Iwaisako¹, Keiji Ueda², Masahiro Fujimuro¹ (1. Kyoto Pharmaceutical Univ., 2. Osaka Medical and Pharmaceutical Univ.)

[30P-pm357S] Functional evaluation of L-serine-modified macromolecular drug carrier for the kidney-targeted delivery of nucleic acid drugs

○Yo Kimura¹, Hidemasa Katsumi¹, Hinako Tatsumi¹, Shoichiro Yasutomi¹, Masaki Morishita¹, Akira Yamamoto^1,2 (1. Kyoto Pharmaceutical Univ, 2. AY Pharmaceutical Laboratory)

[30P-pm358S] Effect of HER2-binding affibody on the delivery of toxin to HER2-positive breast tumor

○Sumito Hattori¹, Yuri Endo¹, Alena Wolkersdorfer², Yoshinori Kato¹, Lorenz Meinel² (1. Hoshi Univ., 2. Univ. of Würzburg)

[30P-pm359S] The Development of a Vaccine for Invasive Candidiasis through Nasal Administration of a Liposomal Vaccine

○Emiri Nomura¹, Rui Tada¹, Tomoko Iwata¹, Satoko Ishihara¹, Hiroshi Kiyono², Yoshiyuki Adachi¹, Jun Kunisawa³, Yoichi Negishi¹ (1. School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 2. Future Medicine Education and Research Organization, Chiba University, 3. Laboratory of Vaccine Materials and Laboratory of Gut Environmental System, Microbial Research Center for Health and Medicine, National Institutes of Biomedical Innovation, Health and Nutrition)

[30P-pm360] Enzyme replacement therapy with D-amino acid oxidase for chronic granulomatosis

○Hideaki Nakamura¹, Hiroyuki Nunoi^2,3, Toyoki Nishimura², Makoto Matsukura¹, Mamoru Haratake¹ (1. Sojo Univ. Facul. Pharm. Sci , 2. Miyazaki Univ. Depart. Med, 3. Ainsenkai Nichinan Hospital)

[30P-pm361] Improve stability and cytotoxicity of self-assembled micelles to induce apoptosis of CD44 overexpressed ovarian cancer cells

○Wen Jen Lin¹, Min-Hua Lai¹ (1. School of Pharmacy, College of Medicine, National Taiwan University.)

[30P-pm362] Effect of nitric oxide-donating diclofenac with high affinity for albumin on pancreatic cancer cell death

○Koji Nishi^1,2, Ryo Kanda¹, Shuhei Imoto^1,2, Kenji Tsukigawa^1,2, Masaki Otagiri¹, Keishi Yamasaki^1,2 (1. Fac. Pharm. Sci., Sojo Univ., 2. DDS Res. Inst., Sojo Univ.)

[30P-pm363] Development of PEG-polyBPA for boron neutron capture therapy; Influence of PEG molecular weight on pharmacokinetics

○Akari Higashide¹, Sui Sakata¹, Shugo Yamashita¹, Shunsuke Kimura¹, Shigeru Negi¹, Akiko Kiriyama¹ (1. Doshisha Women's College of Liberal Arts)

[30P-pm364] Development of PEG-polyBPA for boron neutron capture therapy; Effect of BPA polymerization degree on pharmacokinetics

○Sui Sakata¹, Akari Higashide¹, Shugo Yamashita¹, Shunsuke Kimura¹, Shigeru Negi¹, Akiko Kiriyama¹ (1. Doshisha Women’s College of Liberal Arts)

[30P-pm365S] Enhanced cell death in drug-resistant cancer cells by controlling the intracellular trafficking of anticancer nanoparticles

○Aeri Toratani¹, Kaede Kawasaki¹, Sumika Igarashi¹, Yuichi Yamasaki¹, Susumu Hama¹ (1. Fac. Pharm. Sci., Musashino Univ.)

[30P-pm366S] Development of tumor-penetrable liposomes capable of delivering drugs into cancer cells at the inner regions of tumor in response to slightly acidic pH

○Karin Kitamura¹, Yuichi Yamasaki¹, Susumu Hama¹ (1. Fac. Pharm. Sci., Musashino Univ.)

[30P-pm367S] Development of tumor microenviroment-responsive liposomes modified with a novel blood circulating device

○Kei Morimoto¹, Shoko Itakura², Tomoko Sato¹, Konatsu Ibe¹, Yuichi Yamasaki¹, Susumu Hama¹ (1. Fac. Pharm. Sci., Musashino Univ., 2. Fac. Pharm. Sci., Tokyo Univ. Sci.)

[30P-pm368S] Antitumor effect of liposomes co-encapsulating doxorubicin and mifepristone on the drug-resistant tumor cells

○Yua Yasuda¹, Kumi Kawano¹, Ayami Furuya¹, Yuri Matsuda¹, Chisato Kimura¹, Kotono Yamaguchi¹, Sakura Wakabayashi¹, Yoshiyuki Hattori¹ (1. Hoshi Univ.)

[30P-pm369] Preparation of liposomes co-encapsulating doxorubicin and sorafenib for the treatment of drug-resistant tumor

○Kumi Kawano¹, Momone Okamoto¹, Marina Nakajima¹, Mao Inoue¹, Hiromi Hashimoto¹, Yoshiyuki Hattori¹ (1. Hoshi Univ.)

[30P-pm370S] Development of cellular medicine that induce inflammation only in tumor tissue

○Kenta Tanito¹, Teruki Nii^1,2, Yuta Yokoyama¹, Mayuka Shibata¹, Shoichi Hijii¹, Ryosuke Kaneko², Akihiro Kishimura^1,2,3, Takeshi Mori^1,2, Yoshiki Katayama^1,2,3 (1. Grad. Sch. Syst. Life Sci., Kyushu Univ., 2. Grad. Sch. Engineering, Kyushu Univ., 3. Int. Res. Center for Mol. Syst., Kyushu Univ.)

[30P-pm371S] The development of an intranasal administration cancer liposome vaccine

○Yudai Honda¹, Rui Tada¹, Yukiko Satonaka¹, Hiroko Iida¹, Emi Sato¹, Hiroshi Kiyono², Yoshiyuki Adachi¹, Jun Kunisawa³, Yoichi Negishi¹ (1. School of Pharmarcy, Tokyo University of Pharmacy and Life Sciences, 2. Future Medicine Education and Research Organization, Chiba University, 3. Laboratory of Vaccine Materials and Laboratory of Gut Environmental System, Microbial Research Center for Health and Medicine, National Institutes of Biomedical Innovation, Health and Nutrition)

[30P-pm372S] Influence on phenotypic changes in macrophages by milk-derived extracellular vesicles

○Momoyo Sakai¹, Nobuhito Hamano¹, Ryohei Dozen¹, Hiroshi Ishihara¹ (1. Sch. Pharm., Tokyo Univ. of Pharm. and Life Sci.)

[30P-pm373] In vitro evaluation of TROP2-based bispecific conjugate in human breast cancer cells

○Zizhang Yu¹, Kei Kawano¹, Teruaki Oku¹, Sudath Hapuarachchige², Fumiaki Sato¹, Yoshinori Kato^1,2 (1. Hoshi Univ., 2. The Johns Hopkins Univ. Sch. Med.)

[30P-pm374S] Synthesis of polymer conjugates of retro-inverso bradykinin for tumor drug delivery

○Anthony Assumang¹, Hideaki Nakamura¹, Enoch Appiah¹, Mamoru Haratake¹ (1. sojo univ. Facul. Pharm. Sci.)

[30P-pm375] Antitumor activity of pH-sensitive human serum albumin conjugates of pirarubicin

○Kenji Tsukigawa^1,2, Shuhei Imoto^1,2, Kotone Imamura¹, Naoki Irie¹, Ayano Ando¹, Koji Nishi^1,2, Masaki Otagiri^1,2, Keishi Yamasaki^1,2 (1. Fac. Pharm. Sci., Sojo Univ., 2. DDS Res. Inst., Sojo Univ.)

[30P-pm376] Effect of the combination of cationic lipid and phospholipid on in vitro and in vivo gene-knockdown using siRNA lipoplexes

○Yoshiyuki HATTORI¹, Min Tang¹, Aya Aoki¹, Momoka Ezaki¹, Hana Sakai¹, Ayane Sagawa¹, Nodoka Inoue¹, Kana Tomita¹, Satomi Torii¹, Kei-ichi Ozaki² (1. Hoshi University, 2. Faculty of Pharmaceutical Sciences, Doshisha Women’s College of Liberal Arts)

[30P-pm377S] Effect of cationic lipid, neutral helper lipid, and PEG-lipid on gene-knockdown efficacy after transfection with siRNA lipoplexes prepared by modified ethanol injection method

○Ayana Hattori¹, Hanaka Suzuki¹, Ayumu Ishii¹, Sora Endo¹, Aya Aoki¹, Momoka Ezaki¹, Hana Sakai¹, Min Tang¹, Yoshiyuki Hattori¹ (1. Hoshi Univ.)

[30P-pm378S] Effect of solvents for preparation of siRNA lipoplexes using modified ethanol injection method on gene-knockdown efficacy in the cells

○Hanaka Suzuki¹, Ayana Hattori¹, Ayumu Ishii¹, Sora Endo¹, Aya Aoki¹, Momoka Ezaki¹, Hana Sakai¹, Min Tang¹, Yoshiyuki Hattori¹ (1. Hoshi Univ.)

[30P-pm379S] Effect of anionic polymer coating on gene knockdown effect of siRNA lipoplexes prepared by simply mixing siRNA with lipid-ethanol solution

○Kohei Miura¹, Kumi Kawano¹, Yui Kikuchi¹, Rento Suzuki¹, Sumire Fukushige¹, Yoshiyuki Hattori¹ (1. Hoshi Univ.)

[30P-pm380S] A combination of LNPs and ultrasound-responsive nanobubbles enables site-selective mRNA delivery to skeletal and cardiac muscle

○Tsugumi Miyazawa¹, Koshiro Nakayama¹, Eri Sasaki¹, Atsuto Takeshita¹, Kanako Nakazawa¹, Haruki Hosoi¹, Hiroki Tanaka², Hidetaka Akita², Yoko Takahashi¹, Yoichi Negishi¹ (1. Tokyo University of Pharmacy and Life Sciences, 2. Graduate School of Pharmaceutical Sciences & Faculty of Pharmaceutical Sciences, Tohoku University)

[30P-pm381S] Enhancement intracellular DNA delivery by electroporation using intradermal implantable electrodes

○Manami Aoki¹, Shoko Itakura², Yuya Yoshida^1,3, Kenji Sugibayashi^1,4, Hiroaki Todo¹ (1. Fac. Pharm. Pharm. Sci., Josai Univ., 2. Fac. Pharm. Sci., Tokyo Univ. Sci., 3. Astellas Pharma Inc., 4. Fac. Pharm. Sci., Josai Int. Univ. )

[30P-pm382S] Fundamental study for the construction of a heart failure treatment system using nanobubbles loaded with miRNA-146a and ultrasound

○Atsuto Takeshita¹, Taiki Yamaguchi¹, Kanako Nakazawa¹, Yoko Takahashi¹, Yoichi Negishi¹ (1. School of Pharmacy, Tokyo University of Pharmacy and Life Sciences)

[30P-pm383] Development of cancer targeting micellar system containing nucleic acids using zebrafish breast cancer transplant model

○Mai Hazekawa¹, Dennis Aschmann², Gangyin Zhao², Ewa Snaar-Jagalska², Alexander Kros² (1. Fac.Pharm., Fukuoka Univ., 2. Fac.Sci., Leiden Univ.)

[30P-pm384S] Application of micelles based on side-chain crystalline block co-polymer for drug delivery carriers

○Momoka Funatsu¹, Mai Hazekawa¹, Daisuke Watase¹, Takuya Nishinakagawa¹, Masato Hosokawa¹, Shigeru Yao², Daisuke Ishibashi¹ (1. Fac.Pharm., Fukuoka Univ., 2. Fac.Eng., Fukuoka Univ.)

[30P-pm385] Kidney-targeted gene delivery using microbubbles and ultrasound diagnostic device

○Daiki Omata¹, Lisa Munakata¹, Kazuo Maruyama¹, Kohji Masuda², Ryo Suzuki¹ (1. Fac. Pharm-Sci. Teikyo Univ., 2. Fac. Eng., Tokyo Univ. Agri. Tech.)

[30P-pm386S] Establishment of a Novel Preparation Method for Ultrasound-responsive Nanobubbles Using Microfluidic Technology and Evaluation of Their Utility

○Kento Awaji¹, Taiki Yamaguchi¹, Yoko Takahashi¹, Yoichi negishi¹ (1. Tokyo University of Pharmacy and Life Sciences)

[30P-pm387] Development of cationic polypeptides with hydrophobic side chains for effective antisense oligonucleotide (ASO) delivery

○Fadlina Aulia¹, Jongmin Yum^1,2, Keisuke Kamiya¹, Beob Soo Kim¹, Mitsuru Naito¹, Satomi Ogura¹, Tetsuya Nagata², Takanori Yokota², Satoshi Uchida³, Satoshi Obika⁴, Hyun Jin Kim⁵, Kanjiro Miyata¹ (1. Dept. Material Engineering, Tokyo Univ., 2. TIDE Center, Tokyo Medical and Dental Univ., 3. Adv. Nanomed. Eng., Tokyo Medical and Dental Univ., 4. Grad. Sch. Pharm. Sc., Osaka Univ., 5. Grad. Sch. Eng., Inha Univ.)

[30P-pm388S] Determination of fluorescent probes for the evaluation of styrene-maleic acid copolymer (SMA) emulsion accumulation in cancer cells

○Nanami Kadowaki¹, Toru Takarada¹, Masakazu Fukuda¹, Masafumi Tanaka¹ (1. Kobe.Pharm.Univ)

[30P-pm389] Effect of storage environment on tablet-shaped food with functional claims

○kuribayashi kazumi¹, ayaka ikeda¹, mahiro uta¹ (1. Teikyo Heisei University)

[30P-pm390] Evaluation study of physical pharmacy for generic tablets of amlodipine and pitavastatin

○Kenta Mizoi¹, Hajime Shimano¹, Misato Mashiko¹, Rina Koibuchi¹, Saori Hirota¹, Hiroya Miura¹ (1. IUHW)

[30P-pm391] Supercritical fluid extraction of felbinac from transdermal patches

○Kazuhiro Yamamoto¹, Kanako Wakiguchi¹, Koichi Machida¹, Akira Kotani¹, Hideki Hakamata¹ (1. School of Pharmacy, Tokyo University of Pharmacy and Life Sciences)

[30P-pm392] GC-MS-based screening method for assessing the risk of nitrosamine formation during drug storage

○Yasuhiro Abe¹, Akiko Usui¹, Yuki Takechi-Haraya¹, Hiroyuki Yoshida¹, Ken-ichi Izutsu^1,2, Yoji Sato¹ (1. Natl. Inst. Health Sci., 2. Int. Univ. Health & Welfare)

[30P-pm393] Stability of ezetimibe and atorvastatin combination tablets

○Yoshitada Kubo¹, Mikinori Kurisu², Takeo Ooyashiki², Mio Tamura¹, Tsutomu Nakagawa¹, Yoshihiko Shibayama¹ (1. School of Pharmaceutical Sciences, Health Sciences University of Hokkaido, 2. Kitasaito Hospital)

[30P-pm394] Evaluation of stability of topical dermatologic products under artificial solar lighting.

○Reiko Yutani¹, Tomoka Takatani-Nakase^1,2 (1. Sch. Pharm. Pharm. Sci., Mukogawa Women's Univ., 2. Inst. Biosci., Mukogawa Women's Univ.)

[30P-pm395S] Evaluation of physical properties and usability of Pregabalin OD Tablets in brand-name and generic drug formulations

○Juna Onda¹, Shigeo Akiyama¹, Etsuko Miyamoto^2,3, Hiroto Sato¹, Masaaki Yoneda, Shiro Ishida⁴, Yusuke Hori¹ (1. Tokyo University of Pharmacy and Life Sciences, 2. Non Profit Organization Health & Welfare･Eco-Protect･Area Contribution･Refresh Education･Town Communication, 3. Nijiiro Create Corp, 4. Kagawa School of Pharmaceutical Sciences,Tokushima Bunri University, Department of Pharmacy)

[30P-pm396] Study on assay of ascorbic acid injection using quantitative ¹H-NMR

○Tatsuo Koide¹, Nahoko Uchiyama¹, Junko Hosoe¹, Seiji Tanaka¹, Naoko Masumoto¹, Michiho Ito¹, Naoki Sugimoto¹, Kyoko Ishizuki¹, Hitomi Kan-no¹, Daisuke Ando¹, Tamaki Miyazaki ¹, Yoji Sato¹, Mika Murabayashi², Taeko Shinozaki³, Yoshinori Fujimine⁴, Katsuya Ofuji ⁵, Hitoshi Shimizu⁴, Kazuhiro Fujita ⁵, Takashi Hasebe ⁶, Yumi Asai⁶, Eri Ena⁶, Kohei Kiyota⁷, Yoshinobu Makino⁸, Toru Miura⁹, Yasuhiro Muto⁹, Katsuo Asakura¹⁰, Takako Suematsu¹⁰, Takanori Komatsu¹⁰, Hitomi Muto¹⁰, Ai Kohama¹¹, Shinya Takaoka⁹, Takahiro Nakayama⁹, Takashi Goto¹², Masu Yasuda¹², Tomohiko Ueda¹³, Yukihiro Goda¹ (1. NIHS, 2. Takeda Pharmaceutical Co., Ltd., 3. Daiichi Sankyo Co., Ltd., 4. Otsuka Pharmaceutical Co., Ltd., 5. Chugai Pharmaceutical Co., Ltd., 6. Eisai Co., Ltd., 7. SHIONOGI & Co., Ltd., 8. Juzen Chemical Corp., 9. FUJIFILM Wako Pure Chemical Corp., 10. JEOL Ltd., 11. PMRJ, 12. Nippon Shinyaku Co., Ltd., 13. Sumitomo Pharma Co., Ltd.)

[30P-pm397] Depolymerization of hyaluronic acid by ionized irradiation

○Rumi Yamaoki¹, Masahiko Hirata¹ (1. Osaka Medical and Pharmaceutical University, Faculty of Pharmacy)

[30P-pm398S] The inhalation formulation of disulfiram and non-clinical development for therapy of pulmonary fibrosis

○Naoaki Tanabe¹, Mayu Okada², Taiyo Ikeda³, Kohei Endo², Mayumi Shikano³, Etsuko Toda⁴, Kouji Matsushima¹, Yuya Terashima¹ (1. Grad. Sch. Biol. Sci., Tokyo Univ. of Sci., 2. Grad. Sch. Sci., Tokyo Univ. of Sci., 3. Faculty of Pharma. Sci., Tokyo Univ. of Sci., 4. Dep. of Analytic Human Pathology, Nippon Med. Sch.)

[30P-pm399] Possibility to use reverse iontophoresis as a new application of the transdermal drug sampling tool.

○Rie Yamauchi¹, Shuji Ohno¹, Mizuki Okazaki¹, Mizuki Okada¹, Nobuhiro Inoue¹, Hajime Kubo¹, Kazunori Asai¹ (1. Div. Pharm. Edu. Res., Hoshi Univ.)

[30P-pm400S] Disintegration test of OTC drugs with various drinks.

○Yurika Amanai¹, Mitiko Inuma¹, Toshio Teramura¹ (1. Aomori Univ., Fac. of Pharm. Sci.)

[30P-pm401S] Development and Texture Evaluation of Medication-assisting Food for Bitter-tasting Drugs

○Kyoko Nakajima¹, Haruka Watarai¹, Kana Harada², Serina Hayashi¹, Yoshiaki Fujita², Akihiro Nakamura², Tsutomu Harada² (1. Pharm.,Showa Univ., 2. Grad. Sch. Pharm. Sci., Showa Univ.)

[30P-pm402] Extensive intradermal drug delivery by non-contact iontophoresis

Haruki Konishi¹, Mizune Ozono², ○Kentaro Kogure² (1. Grad. Sch. Pharm. Sci., Tokushima Univ., 2. Grad. Sch. Biomed. Sci., Tokushima Univ.)

[30P-pm403S] Development of an effective psoriasis treatment by combining tacrolimus-encapsulated liposomes and iontophoresis

○Seiko Nakamura¹, Mizune Ozono², Karen Yanagi³, Kentaro Kogure² (1. Department of Pharmaceutical Health Chemistry, Graduate School of Pharmaceutical Sciences, Tokushima University, 2. Department of Pharmaceutical Health Chemistry, Graduate School of Biomedical Sciences, Tokushima University, 3. Department of Pharmaceutical Health Chemistry, Faculty of Pharmaceutical Sciences, Tokushima University)

[30P-pm404S] Selection method of formulation base for human patch test considering the solubility parameters of allergen chemicals and the formulation base

○Airi Kato¹, Rei Mizuno¹, Kenji Sugibayashi^1,2, Hiroaki Todo¹ (1. Fac. Pharm. Pharm. Sci., Josai Univ., 2. Fac. Pharm. Sci., Josai Int. Univ.)

[30P-pm405S] Skin penetration enhance effect of nanoparticle collagen.

○Chisato Takedomi¹, Yoshihiro Tokudome^1,2 (1. Grad. Sch. Adv. Health Sci., Saga Univ., 2. Regional Innovation Center, Saga Univ.)

[30P-pm406S] Evaluation of skin distribution of drug after its administration with pyrodrive jet injector

○Yuuki Adachi¹, Kazuya Inamura¹, Motoki Miyadera¹, Kenji Sugibayashi^1,2, Shoko Itakura³, Hiroaki Todo¹ (1. Fac. Pharm. Pharm. Sci., Josai Univ., 2. Fac. Pharm. Sci., Josai Int., 3. Fac. Pharm. Sci., Tokyo Univ. Sci.)

[30P-pm407S] Neuroprotective effects in the brain by intranasal administration of 2-ethyl-6-methyl-3-hydroxypyridine succinate

○Kai Tsukada¹, Keisuke Yanagihara¹, Mitsuyoshi Fukuda², Taiki Nagatomo¹, Naoto Suzuki¹, Toyofumi Suzuki¹ (1. Nihon University, 2. International University of Health and Welfare)

[30P-pm408] Evaluation of dissolution profiles of powdery drugs by Raman spectroscopy and its application to the prediction of nasal drug absorption V

○Tomoyuki Furubayashi¹, Akiko Tanaka¹, Toshiyasu Sakane¹ (1. Kobe Pharmaceutical University)

[30P-pm409] Brain uptake of oxytocin after intranasal administration

○Tanaka Akiko¹, Momoko Morisaki¹, Hidemasa Katsumi², Tomoyuki Furubayashi¹, Toshiyasu Sakane¹ (1. Kobe Pharmaceutical Univ., 2. Kyoto Pharmaceutical Univ.)

[30P-pm410S] Substrate specificity of MCT6/SLC16A5 using fluorescent probes

○Koki Sugiyama¹, Hiroe Shimano¹, Kei Higuchi¹, Hisanao Kishimoto¹, Katsuhisa Inoue¹ (1. Sch. Pharm., Tokyo Univ. Pharm.)

Session information

[30P-pm] Science for Drug Formulation

Authentication